Research ArticleClinical Studies

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

MARTIN SVATON, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, LENKA JAKUBIKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MICHAL JIROUSEK, JANA KREJCI, DANIEL KREJCI, ONDREJ BILEK, JIRI BLAZEK, KAROLINA HURDALKOVA, MAGDA BARINOVA and BOHUSLAV MELICHAR
Anticancer Research April 2020, 40 (4) 2209-2217; DOI: https://doi.org/10.21873/anticanres.14182

Article Information

vol. 40 no. 4 2209-2217
DOI 
https://doi.org/10.21873/anticanres.14182
PubMed 
32234916
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 6, 2020
  • Revision received February 24, 2020
  • Accepted February 29, 2020
  • Published online March 31, 2020.
Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MARTIN SVATON1⇑,
  2. MILADA ZEMANOVA2,
  3. PETRA ZEMANOVA2,
  4. JURAJ KULTAN3,
  5. ONDREJ FISCHER3,
  6. JANA SKRICKOVA4,
  7. LENKA JAKUBIKOVA4,
  8. MARKETA CERNOVSKA5,
  9. MICHAL HRNCIARIK6,
  10. MICHAL JIROUSEK6,
  11. JANA KREJCI7,
  12. DANIEL KREJCI7,
  13. ONDREJ BILEK8,
  14. JIRI BLAZEK1,
  15. KAROLINA HURDALKOVA9,
  16. MAGDA BARINOVA9 and
  17. BOHUSLAV MELICHAR10
  1. 1Department of Pneumology and Phthisiology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic
  2. 2Department of Oncology, Charles University, First Faculty of Medicine in Prague, Prague, Czech Republic
  3. 3Department of Respiratory Medicine, Palacky University, Faculty of Medicine and Dentistry, Olomouc, Czech Republic
  4. 4Department of Respiratory Diseases and TB, Faculty of Medicine, Masaryk University Brno and University Hospital Brno, Brno, Czech Republic
  5. 5Department of Respiratory Medicine, First Faculty of Medicine of Charles University, Thomayer Hospital Prague, Prague, Czech Republic
  6. 6Department of Pneumology, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic
  7. 7Department of Pneumology, Charles University, Faculty of Medicine in Prague, Prague, Czech Republic
  8. 8Department of Comprehensive Oncology, Masaryk Institute of Oncology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
  9. 9Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
  10. 10Department of Oncology, Palacky University, Faculty of Medicine and Dentistry, Olomouc, Czech Republic
  1. Correspondence to: Martin Svaton, Department of Pneumology and Phtisiology, Charles University, Faculty of Medicine in Pilsen, Husova 3, 301 00, Pilsen, Czech Republic. Tel: +420 377402973, e-mail: svatonm{at}fnplzen.cz
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, LENKA JAKUBIKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MICHAL JIROUSEK, JANA KREJCI, DANIEL KREJCI, ONDREJ BILEK, JIRI BLAZEK, KAROLINA HURDALKOVA, MAGDA BARINOVA, BOHUSLAV MELICHAR
Anticancer Research Apr 2020, 40 (4) 2209-2217; DOI: 10.21873/anticanres.14182
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords